Kimberly-Clark to buy Tylenol maker Kenvue for nearly $50 billion
                            
                                Neutral                            
                            
                                0.0                            
                        
                        
                    Manufacturing giant Kimberly-Clark is set to acquire Kenvue, the maker of Tylenol, for $48.7 billion. CBS News MoneyWatch correspondent Kelly O'Grady has more details.                
                 
                 
                Pulse AI Analysis
                        Pulse analysis not available yet. Click "Get Pulse" above.                    
                     This analysis was generated using Pulse AI, Glideslope's proprietary AI engine designed to interpret market sentiment and economic signals. Results are for informational purposes only and do not constitute financial advice.